|
1.
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2.
|
Gustin DM and Brenner DE: Chemoprevention
of colon cancer: current status and future prospects. Cancer Metast
Rev. 21:323–348. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Lin J, Chen Y, Wei L, Chen X, Xu W, Hong
Z, Sferra TJ and Peng J: Hedyotis diffusa Willd extract
induces apoptosis via activation of the mitochondrion-dependent
pathway in human colon carcinoma cells. Int J Oncol. 37:1331–1338.
2010.
|
|
4.
|
Gordaliza M: Natural products as leads to
anticancer drugs. Clin Transl Oncol. 9:767–776. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Ji HF, Li XJ and Zhang HY: Natural
products and drug discovery. Can thousands of years of ancient
medical knowledge lead us to new and powerful drug combinations in
the fight against cancer and dementia? EMBO Rep. 10:194–200.
2009.PubMed/NCBI
|
|
6.
|
Folkman J: Tumor angiogenesis: therapeutic
implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Folkman J: Angiogenesis. Annu Rev Med.
57:1–18. 2006. View Article : Google Scholar
|
|
8.
|
Cook KM and Figg WD: Angiogenesis
inhibitors: current strategies and future prospects. CA Cancer J
Clin. 60:222–243. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Ingham PW, Nakano Y and Seger C:
Mechanisms and functions of Hedgehog signalling across the metazoa.
Nat Rev Genet. 12:393–406. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Zhang S, Wang Y, Mao JH, Hsieh D, Kim IJ,
Hu LM, Xu Z, Long H, Jablons DM and You L: Inhibition of CK2α
down-regulates Hedgehog/Gli signaling leading to a reduction of a
stem-like side population in human lung cancer cells. PLoS One.
7:e389962012.
|
|
11.
|
Theunissen JW and de Sauvage FJ: Paracrine
Hedgehog signaling in cancer. Cancer Res. 69:6007–6010. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Mazumdar T, DeVecchio J, Shi T, Jones J,
Agyeman A and Houghton JA: Hedgehog signaling drives cellular
survival in human colon carcinoma cells. Cancer Res. 71:1092–1102.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Yoshikawa K, Shimada M, Miyamoto H,
Higashijima J, Miyatani T, Nishioka M, Kurita N, Iwata T and Uehara
H: Sonic hedgehog relates to colorectal carcinogenesis. J
Gastroenterol. 44:1113–1117. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Varnat F, Duquet A, Malerba M, Zbinden M,
Mas C, Gervaz P and Ruiz i Altaba A: Human colon cancer epithelial
cells harbour active HEDGEHOG-GLI signalling that is essential for
tumour growth, recurrence, metastasis and stem cell survival and
expansion. EMBO Mol Med. 1:338–351. 2009. View Article : Google Scholar
|
|
15.
|
Das S, Tucker JA, Khullar S, Samant RS and
Shevde LA: Hedgehog signaling in tumor cells facilitates
osteoblast-enhanced osteolytic metastases. PLoS One. 7:e343742012.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Sahebjam S, Siu LL and Razak AA: The
utility of Hedgehog signaling pathway inhibition for cancer.
Oncologist. 17:1090–1099. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Wei L, Lin J, Xu W, Cai Q, Shen A, Hong Z
and Peng J: Scutellaria barbata D. Don inhibits tumor
angiogenesis via suppression of Hedgehog pathway in a mouse model
of colorectal cancer. Int J Mol Sci. 13:9419–9430. 2012. View Article : Google Scholar
|
|
18.
|
Lum L and Beachy PA: The Hedgehog response
network: sensors, switches, and routers. Science. 304:1755–1759.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Varjosalo M and Taipale J: Hedgehog:
functions and mechanisms. Genes Dev. 22:2454–2472. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Pola R, Ling LE, Silver M, Corbley MJ,
Kearney M, Pepinsky RB, Shapiro R, Taylor FR, Baker DP and Asahara
T: The morphogen Sonic hedgehog is an indirect angiogenic agent
upregulating two families of angiogenic growth factors. Nat Med.
7:706–711. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Claret S, Sanial M and Plessis A: Evidence
for a novel feedback loop in the Hedgehog pathway involving
smoothened and fused. Curr Biol. 17:1326–1333. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Kerbel RS: Tumor angiogenesis. N Engl J
Med. 358:2039–2049. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Prasad S, Yadav VR, Sung B, Reuter S,
Kannappan R, Deorukhkar A, Diagaradjane P, Wei C,
Baladandayuthapani V, Krishnan S, Guha S and Aggarwal BB: Ursolic
acid inhibits growth and metastasis of human colorectal cancer in
an orthotopic nude mouse model by targeting multiple cell signaling
pathways: chemosensitization with capecitabine. Clin Cancer Res.
18:4942–4953. 2012. View Article : Google Scholar
|
|
24.
|
Dai J, Wan S, Zhou F, Myers RE, Guo X, Li
B, Fu X, Palazzo JP, Dou K, Yang H and Xing J: Genetic polymorphism
in a VEGF-independent angiogenesis gene ANGPT1 and overall survival
of colorectal cancer patients after surgical resection. PLoS One.
7:e347582012. View Article : Google Scholar
|
|
25.
|
Lin J, Wei L, Xu W, Hong Z, Liu X and Peng
J: Effect of Hedyotis diffusa Willd extract on tumor
angiogenesis. Mol Med Rep. 4:1283–1288. 2011.
|
|
26.
|
Ferrara N, Gerber HP and LeCouter J: The
biology of VEGF and its receptors. Nat Med. 9:669–676. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Shigami SI, Arii S, Furutani M, Niwano M,
Harada T, Mizumoto M, Mori A, Onodera H and Imamura M: Predictive
value of vascular endothelial growth factor (VEGF) in metastasis
and prognosis of human colorectal cancer. Br J Cancer.
78:1379–1384. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Gille H, Kowalski J, Li B, LeCouter J,
Moffat B, Zioncheck TF, Pelletier N and Ferrara N: Analysis of
biological effects and signaling properties of Flt-1 (VEGFR-1) and
KDR (VEGFR-2). A reassessment using novel receptor-specific
vascular endothelial growth factor mutants. J Biol Chem.
276:3222–3230. 2001. View Article : Google Scholar
|
|
29.
|
Ferrara N: Role of vascular endothelial
growth factor in physiologic and pathologic angiogenesis:
therapeutic implications. Semin Oncol. 29:10–14. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Risau W: Mechanisms of angiogenesis.
Nature. 386:671–674. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Ren F, Liu G, Zhang L and Niu G: Studies
on chemical constituents of Hedyotis diffusa Willd. Chin
Pharm J. 40:502–504. 2005.
|
|
32.
|
Ahmad R, Shaari K, Lajis NH, Hamzah AS,
Ismail NH and Kitajima M: Anthraquinones from Hedyotis
capitellata. Phytochemistry. 66:1141–1147. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Li C, Xue X, Zhou D, Zhang F, Xu Q, Ren L
and Liang X: Analysis of iridoid glucosides in Hedyotis
diffusa by high-performance liquid chromatography/electrospray
ionization tandem mass spectrometry. J Pharm Biomed Anal.
48:205–211. 2008.
|
|
34.
|
Cai Q, Lin J, Wei L, Zhang L, Wang L, Zhan
Y, Zeng J, Xu W, Shen A, Hong Z and Peng J: Hedyotis diffusa
Willd inhibits colorectal cancer growth in vivo via inhibition of
STAT3 signaling pathway. Int J Mol Sci. 13:6117–6128. 2012.
View Article : Google Scholar
|
|
35.
|
Chen HX and Cleck JN: Adverse effects of
anticancer agents that target the VEGF pathway. Nat Rev Clin Oncol.
6:465–477. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Zangari M, Fink LM, Elice F, Zhan F,
Adcock DM and Tricot GJ: Thrombotic events in patients with cancer
receiving antiangiogenesis agents. J Clin Oncol. 27:4865–4873.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Higa GM and Abraham J: Biological
mechanisms of bevacizumab-associated adverse events. Expert Rev
Anticancer Ther. 9:999–1007. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Jain RK: Tumor angiogenesis and
accessibility: role of vascular endothelial growth factor. Semin
Oncol. 29:3–9. 2002. View Article : Google Scholar : PubMed/NCBI
|
